Related Experiment Video
Updated: Jan 31, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
Heavy Drinking and Treatment among HIV/HCV Co-Infected Patients
Jennifer C Elliott1,2, Noga Shalev3, Deborah S Hasin1,2,4
1New York State Psychiatric Institute, USA.
Insights
Individuals with HIV/HCV co-infection who drink despite health problems access less Hepatitis C virus treatment. This drinking pattern may identify those at risk of being untreated.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis C virus (HCV) treatments are highly effective.
- Individuals with HIV/HCV co-infection represent a high-risk population.
- Understanding barriers to HCV treatment access is crucial for this group.
Purpose of the Study:
- To investigate the relationship between alcohol consumption and HCV treatment access in patients with HIV/HCV co-infection.
- To identify specific drinking patterns associated with reduced treatment engagement.
Main Methods:
- A survey was administered to 210 patients at a sexual health clinic.
- 39 patients with HIV/HCV co-infection completed self-report measures on drinking and HCV treatment history.
- Statistical analyses examined the association between drinking behaviors and HCV treatment outcomes.
Main Results:
- Patients reporting drinking despite health problems had significantly lower HCV treatment rates (p = 0.035).
- Drinking despite health problems was not associated with provider recommendation for HCV treatment.
- Binge drinking and general alcohol consumption did not correlate with HCV treatment access or HIV treatment.
Conclusions:
- Alcohol consumption, particularly drinking despite health problems, is linked to reduced access to Hepatitis C virus treatment among those with HIV/HCV co-infection.
- The pattern of drinking despite health problems may serve as a valuable screening tool to identify untreated individuals.
- Interventions targeting alcohol reduction and treatment engagement are urgently needed for this vulnerable population.
Aims:
Given the efficacy of new medications for Hepatitis C virus (HCV), we aimed to determine whether drinking relates to HCV treatment access among the high-risk group of individuals with HIV/HCV co-infection.
Methods:
We sampled 210 patients in a sexual health clinic; of these, 39 reported HIV/HCV co-infection (79.49% male; 56.41% Black). Patients completed a self-report survey on drinking and treatment history.
Results:
Those drinking despite health problems reported less HCV treatment (p =0.035). Drinking despite health problems did not relate to whether HCV treatment was recommended by providers, and binge drinking did not relate to either HCV outcome. Drinking was unrelated to HIV treatment.
Conclusions:
HIV/HCV co-infected individuals drinking despite health problems are in urgent need of attention, to reduce drinking and increase engagement in treatment. Drinking despite health problems m ay serve as an effective screening question to identify HIV/HCV co-infected drinkers who are most at risk of being untreated.
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Stages of Infection
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers
Patient-centered Care
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

